Ark Biotech
Signal active
Organization
Contact Information
Overview
Ark Biotech develops bioreactors and operating systems for the industrial production of cultivated meat.
About
Industries
Biotechnology, Food and Beverage, Industrial, Alternative Protein
Founded
2021
Employees
11-50
Headquarters locations
New York, New York, United States, North America
Social
N/A
Profile Resume
Ark Biotech headquartered in New York, New York, United States, North America, operates in the Biotechnology, Food and Beverage, Industrial, Alternative Protein sector. The company focuses on Biotechnology and has secured $800.7M in funding across 48 round(s). With a team of 11-50 employees, Ark Biotech is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Ark Biotech, raised $8.2M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$16.7M
Details
1
Ark Biotech has raised a total of $16.7M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Seed | 2.5M |
Investors
Ark Biotech is funded by 9 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Kevin Carter | - | FUNDING ROUND - Kevin Carter | 2.5M |
| David Barber | - | FUNDING ROUND - David Barber | 2.5M |
| Ark Biotech | - | FUNDING ROUND - Ark Biotech | 2.5M |
| Natalie Portman | - | FUNDING ROUND - Natalie Portman | 2.5M |
Recent Activity
There is no recent news or activity for this profile.